Asia Pacific Healthcare Contract Research Organization Market Size & Outlook

The healthcare contract research organization market in Asia Pacific is expected to reach a projected revenue of US$ 41,087.4 million by 2030. A compound annual growth rate of 8.6% is expected of Asia Pacific healthcare contract research organization market from 2024 to 2030.
Revenue, 2023 (US$M)
$23,049.5
Forecast, 2030 (US$M)
$41,087.4
CAGR, 2024 - 2030
8.6%
Report Coverage
Asia Pacific

Asia Pacific healthcare contract research organization market, 2018-2030 (US$M)

Asia

Related Markets

Asia Pacific healthcare contract research organization market highlights

  • The Asia Pacific healthcare contract research organization market generated a revenue of USD 23,049.5 million in 2023.
  • The market is expected to grow at a CAGR of 8.6% from 2024 to 2030.
  • In terms of segment, clinical was the largest revenue generating type in 2023.
  • Pre-Clinical is the most lucrative type segment registering the fastest growth during the forecast period.
  • Country-wise, India is expected to register the highest CAGR from 2024 to 2030.


Asia Pacific data book summary

Market revenue in 2023USD 23,049.5 million
Market revenue in 2030USD 41,087.4 million
Growth rate8.6% (CAGR from 2023 to 2030)
Largest segmentClinical
Fastest growing segmentPre-Clinical
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationDrug Discovery, Pre-Clinical, Clinical
Key market players worldwideIcon PLC, Charles River Laboratories International Inc, IQVIA Holdings Inc, GVK Biosciences, Labcorp Holdings Inc, Thermo Fisher Scientific Inc, PAREXEL, Dassault Systemes SE, Pharmaron Beijing Co Ltd Ordinary Shares - Class H, SGS AG, Worldwide Clinical Trials, Wuxi AppTec Co Ltd, Caidya


Other key industry trends

  • In terms of revenue, Asia Pacific region accounted for 45.6% of the global healthcare contract research organization market in 2023.
  • Globally, Asia Pacific is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 41,087.4 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Healthcare Contract Research Organization Market Scope

Healthcare contract research organization market segmentation & scope
Target validation
Lead identification
Lead optimization
Pre-Clinical
Phase I Trial Services
Phase II Trial Services
Phase III Trial Services
Phase IV Trial Services
Project Management/Clinical Supply Management
Data Management
Regulatory/Medical Affairs
Medical Writing
Clinical Monitoring
Quality Management/ Assurance
Bio-statistics
Investigator Payments
Sterility Testing
Container/Closure Testing
Extractables and Leachable Testing
Environmental Monitoring (Including Microbiology Testing)
Disinfectant Efficacy Studies
Other
Patient and site Recruitment
Technology
Others
Oncology
CNS Disorders
Infectious Diseases
Immunological Disorders
Cardiovascular Disease
Respiratory Diseases
Diabetes
Ophthalmology
Pain Management
Other
Molecule Type
Pharmaceutical
Small Molecules
Biologics
Medical Device

Healthcare Contract Research Organization Market Companies

Name Profile # Employees HQ Website

Asia Pacific healthcare contract research organization market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to healthcare contract research organization market will help companies and investors design strategic landscapes.


Clinical was the largest segment with a revenue share of 75.89% in 2023. Horizon Databook has segmented the Asia Pacific healthcare contract research organization market based on drug discovery, pre-clinical, clinical covering the revenue growth of each sub-segment from 2018 to 2030.


Asia Pacific is projected to be the fastest-growing market for clinical trials due to the changes in evaluation standards by regulatory organizations.

The growing patient pool and the outsourcing trend in the biopharmaceutical industry, particularly during the clinical stages of R&D, contribute to the growing number of clinical studies in the region. India has minimal regulations on the import & export of clinical supplies, making the process faster.

However, China has a large patient pool with a few regulatory adjustments, which is expected to contribute to its largest market share. The ease of access to a treatment-naïve patient pool in these countries drives advanced outsourcing of clinical trials and related activities.

Reasons to subscribe to Asia Pacific healthcare contract research organization market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Asia Pacific healthcare contract research organization market databook

  • Our clientele includes a mix of healthcare contract research organization market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific healthcare contract research organization market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific healthcare contract research organization market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Asia Pacific healthcare contract research organization market size, by country, 2018-2030 (US$M)

Asia Pacific Healthcare Contract Research Organization Market Outlook Share, 2023 & 2030 (US$M)

Asia Pacific healthcare contract research organization market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more